OCR Text |
Show CHARLES H. MONSON PRIZE WINNER SPRING 2013 56 Gilead Sciences. (2011). Gilead expands access program for medications in developing world [Press release]. Retrieved July 30, 2012, from http://investors.gilead.com/ phonix.zhtml?c=69964&p=irol-newsArticle&ID=1584101 Global Health Watch, (n.d.). Medicines patent pool [Press release]. Retrieved July 30, 2012, from http://www.ghwatch.org/sites/www.ghwatch.org/files/ PatentPoolsSideEventl 10518.pdf Haakonsson, S. J., & Richey, L. A. (2007). TRIPS and public health: The Doha declaration and Africa. Development Policy Review, 25(1), 71-90. Herper, M. (2012, February 10). The truly staggering cost of inventing new drugs. Forbes, Retrieved June 30, 2012, from http://www.forbes.com/sites/ matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/ Hirschler, B. (2011, July 12). Gilead kickstarts patent pool for AIDS drugs. Reuters. Retrieved from http://www.reuters.com/article/2011/07/12/us-aids-patents-idUSTRE76B0YW20110712 Love, R. (2007). Corporate wealth or public health? WTO/TRIPS flexibilities and access to HIV/AIDS antiretroviral drugs by developing countries. Development in Practice, 17(2), 208-220. Medecins Sans Frontieres. (2011). Johnson & Johnson turns its back on AIDS patients. Retrieved from Medecins Sans Frontieres website on July 25, 2012: http://www.doctorswithoutborders.org/press/release.cfm?id=5209&cat=press-release& v=2 Medicines Patent Pool. (2012). Medicines patent pool annual report 2010-2011. Retrieved from Medicines Patent Pool website on July 25, 2012: http://www.medicinespatentpool.org/wp-content/uploads/Medicines-Patent-Pool- Annual-Report-2010-2011-RevFinal.pdf Nature. (2009). Drug patent pools start to take shape. Nature, 458, 562. Retrieved July 23, 2012, from http://www.nature.com/news/2009/090401/full/458562c.html Star-Ledger Editorial Board. (2011, May 1). To save lives, Johnson & Johnson should jump into the patent pool. The Star-Ledger. Retrieved July 25, 201 2, from http://blog.nj.com/njv_editorial_page/2011/05/to_save_l ives_johnson_johnson.htm Subhan, J. (2006). Scrutinized: The TRIPS agreement and public health. McGill Journal of Medicine, 9(2), 152-159. Thomas, J. R. Library of Congress, (2001). HIV/AIDS drugs, patents and the TRIPS agreement: Issues and options. Washington, DC: Congressional Research Service. Wise, J. (2006). Access to AIDS medicines stumbles on trade rules. Bulletin of the World Health Organization, 84(5), 337-424. Retrieved from http://www.who.int/ bu I let in/volumes/84/5/news10506/en/i ndex.html |